PCM
FSTX

Prelude Capital Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Prelude Capital Management’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-60,807
Closed -$384K – 1524
2022
Q4 		$384K Buy
60,807
+41,719
+219% +$264K 0.02% 597
2022
Q3 		$98K Sell
19,088
-17,190
-47% -$88.3K ﹤0.01% 1138
2022
Q2 		$227K Buy
+36,278
New +$227K 0.01% 1034